Dual Add-On Therapy of Gemigliptin and Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study
Diabetes Obes Metab 2024 Jul 08;[EPub Ahead of Print], KA Han, YC Hwang, SJ Moon, HC Cho, HJ Yoo, SH Choi, S Chon, KA Kim, TN Kim, JG Kang, CY Park, JC Won, E Cho, J Kim, KS ParkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.